Total Payments
$3,341
2024 Payments
$2,332
Companies
25
Transactions
71
Payment Breakdown by Category
Consulting$2,200 (65.9%)
Food & Beverage$1,079 (32.3%)
Education$61.87 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,200 | 6 | 65.9% |
| Food and Beverage | $1,079 | 56 | 32.3% |
| Education | $61.87 | 4 | 1.9% |
| Unspecified | $0 | 5 | 0.0% |
Payments by Type
General
$3,341
66 transactions
Ownership
$0
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| MIMEDX Group, Inc. | $2,200 | 6 | $0 (2024) |
| PFIZER INC. | $222.83 | 11 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $197.87 | 8 | $0 (2023) |
| AbbVie Inc. | $104.85 | 6 | $0 (2023) |
| MAYNE PHARMA COMMERCIAL LLC | $84.49 | 4 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $74.81 | 3 | $0 (2018) |
| MILLICENT US INC | $68.81 | 4 | $0 (2024) |
| Astellas Pharma US Inc | $67.46 | 4 | $0 (2024) |
| AMAG Pharmaceuticals, Inc. | $48.52 | 3 | $0 (2018) |
| Allergan Inc. | $39.46 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,332 | 15 | MIMEDX Group, Inc. ($2,200) |
| 2023 | $265.54 | 14 | MAYNE PHARMA COMMERCIAL LLC ($73.27) |
| 2022 | $114.13 | 6 | PFIZER INC. ($53.23) |
| 2021 | $124.23 | 8 | PFIZER INC. ($35.24) |
| 2020 | $35.21 | 3 | Bayer HealthCare Pharmaceuticals Inc. ($19.61) |
| 2019 | $85.86 | 5 | PFIZER INC. ($33.43) |
| 2018 | $209.92 | 9 | Bayer HealthCare Pharmaceuticals Inc. ($89.59) |
| 2017 | $173.98 | 11 | PFIZER INC. ($59.68) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | MIMEDX Group, Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 11/21/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $11.22 | General |
| 10/24/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: CONTRACEPTIVE | ||||||
| 10/01/2024 | MIMEDX Group, Inc. | — | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| 09/12/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: VACCINES | ||||||
| 08/15/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: ETONOGESTREL | ||||||
| 07/01/2024 | MIMEDX Group, Inc. | — | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| 06/03/2024 | MIMEDX Group, Inc. | — | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| 05/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Biological | ||||||
| 05/01/2024 | MIMEDX Group, Inc. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 04/01/2024 | MIMEDX Group, Inc. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 02/01/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Insomnia | ||||||
| 01/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Biological | ||||||
| 01/11/2024 | MILLICENT US INC | INTRAROSA (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 2024 | Unified Women's Healthcare, LP | — | — | — | $0.00 | Ownership |
| 12/07/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kyleena (Drug), Mirena, Skyla | Food and Beverage | In-kind items and services | $31.20 | General |
| Category: Womens Health | ||||||
| 12/05/2023 | AbbVie Inc. | ORILISSA (Drug), LO LOESTRIN FE | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: WOMENS HEALTH | ||||||
| 11/18/2023 | MILLICENT US INC | INTRAROSA (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 11/02/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: WOMENS HEALTH | ||||||
| 10/04/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Biological | ||||||
| 09/07/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $19.79 | General |
| 08/04/2023 | MILLICENT US INC | INTRAROSA (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 06/14/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Biological | ||||||
| 05/11/2023 | MILLICENT US INC | FEMRING (Drug) | Education | In-kind items and services | $13.35 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 05/04/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: WOMENS HEALTH | ||||||
About Dr. Gwen Webster, M.D
Dr. Gwen Webster, M.D is a Specialist healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1902801814.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gwen Webster, M.D has received a total of $3,341 in payments from pharmaceutical and medical device companies, with $2,332 received in 2024. These payments were reported across 71 transactions from 25 companies. The most common payment nature is "Consulting Fee" ($2,200).
Ad
Practice Information
- Specialty Specialist
- Location Plano, TX
- Active Since 06/16/2005
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1902801814
Products in Payments
- PREMARIN (Drug) $145.33
- Kyleena (Drug) $141.49
- LO LOESTRIN FE (Drug) $88.75
- INTRAROSA (Drug) $85.88
- NEXPLANON (Drug) $76.81
- Veozah (Drug) $67.46
- PREMARIN ORALS (Drug) $59.68
- Essure (Device) $56.38
- ORILISSA (Drug) $28.13
- MYFEMBREE (Drug) $21.83
- Xulane (Drug) $20.33
- SOLOSEC (Drug) $19.10
- Phexxi (Drug) $18.09
- ABRYSVO (Biological) $17.82
- BIJUVA (Drug) $16.75
- Endosee (Device) $16.61
- QUVIVIQ (Drug) $15.64
- NUVARING (Drug) $15.63
- ORIAHNN (Drug) $15.60
- DILAPAN-S (Device) $14.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Plano
F. Barber, M.d, M.D
Specialist — Payments: $362,181
Specialist $362,181
Dr. Frances Herbert, M.d, M.D
Specialist — Payments: $110,457
Specialist $110,457
Dr. Rajesh Arakal, M.d, M.D
Specialist — Payments: $100,281
Specialist $100,281
Dr. Jeffrey Adelglass, M.d, M.D
Specialist — Payments: $39,291
Specialist $39,291
Dr. Robert Wilcox, Md Pa, MD PA
Specialist — Payments: $25,752
Specialist $25,752
Dr. Aaron Bransky, Md, MD
Specialist — Payments: $25,257
Specialist $25,257